nodes	percent_of_prediction	percent_of_DWPC	metapath
Ticagrelor—ABCB1—Ethinyl Estradiol—osteoporosis	0.0827	0.133	CbGbCtD
Ticagrelor—CYP3A4—Calcitriol—osteoporosis	0.0769	0.124	CbGbCtD
Ticagrelor—CYP3A4—Estropipate—osteoporosis	0.0769	0.124	CbGbCtD
Ticagrelor—CYP3A4—Ergocalciferol—osteoporosis	0.0614	0.099	CbGbCtD
Ticagrelor—ABCB1—Conjugated Estrogens—osteoporosis	0.0607	0.0978	CbGbCtD
Ticagrelor—ABCB1—Estradiol—osteoporosis	0.0533	0.0859	CbGbCtD
Ticagrelor—CYP3A4—Raloxifene—osteoporosis	0.0513	0.0827	CbGbCtD
Ticagrelor—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0495	0.0798	CbGbCtD
Ticagrelor—CYP3A4—Cholecalciferol—osteoporosis	0.0396	0.0638	CbGbCtD
Ticagrelor—CYP3A4—Conjugated Estrogens—osteoporosis	0.0364	0.0586	CbGbCtD
Ticagrelor—CYP3A4—Estradiol—osteoporosis	0.0319	0.0514	CbGbCtD
Ticagrelor—ABCB1—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.00352	0.0944	CbGpPWpGaD
Ticagrelor—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.00217	0.0582	CbGpPWpGaD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—WDR1—osteoporosis	0.00144	0.0387	CbGpPWpGaD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—CAP1—osteoporosis	0.00114	0.0306	CbGpPWpGaD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—MGLL—osteoporosis	0.000906	0.0243	CbGpPWpGaD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—PLEK—osteoporosis	0.000829	0.0222	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—WDR1—osteoporosis	0.000744	0.0199	CbGpPWpGaD
Ticagrelor—ABCB1—HIF-1-alpha transcription factor network—PKM—osteoporosis	0.000721	0.0193	CbGpPWpGaD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—TLN1—osteoporosis	0.000714	0.0191	CbGpPWpGaD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—VCL—osteoporosis	0.000705	0.0189	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—CALCR—osteoporosis	0.000657	0.0176	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—PTH1R—osteoporosis	0.000657	0.0176	CbGpPWpGaD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—RAP1A—osteoporosis	0.000589	0.0158	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—CAP1—osteoporosis	0.000588	0.0158	CbGpPWpGaD
Ticagrelor—ABCB1—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	0.000563	0.0151	CbGpPWpGaD
Ticagrelor—P2RY12—G alpha (i) signalling events—CNR2—osteoporosis	0.000556	0.0149	CbGpPWpGaD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—FGA—osteoporosis	0.000534	0.0143	CbGpPWpGaD
Ticagrelor—P2RY12—GPCRs, Class A Rhodopsin-like—CNR2—osteoporosis	0.000516	0.0138	CbGpPWpGaD
Ticagrelor—Feeling abnormal—Alendronate—osteoporosis	0.000511	0.00149	CcSEcCtD
Ticagrelor—Malnutrition—Conjugated Estrogens—osteoporosis	0.00051	0.00149	CcSEcCtD
Ticagrelor—Loss of consciousness—Pamidronate—osteoporosis	0.000509	0.00149	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Alendronate—osteoporosis	0.000507	0.00148	CcSEcCtD
Ticagrelor—Cough—Pamidronate—osteoporosis	0.000506	0.00148	CcSEcCtD
Ticagrelor—Constipation—Calcitriol—osteoporosis	0.000506	0.00148	CcSEcCtD
Ticagrelor—ABCB1—Allograft Rejection—TUBA1B—osteoporosis	0.000503	0.0135	CbGpPWpGaD
Ticagrelor—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.000501	0.00146	CcSEcCtD
Ticagrelor—Hypertension—Pamidronate—osteoporosis	0.0005	0.00146	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Raloxifene—osteoporosis	0.000499	0.00146	CcSEcCtD
Ticagrelor—Diarrhoea—Etidronic acid—osteoporosis	0.000498	0.00146	CcSEcCtD
Ticagrelor—Haematuria—Estradiol—osteoporosis	0.000498	0.00145	CcSEcCtD
Ticagrelor—Body temperature increased—Estropipate—osteoporosis	0.000498	0.00145	CcSEcCtD
Ticagrelor—Abdominal pain—Estropipate—osteoporosis	0.000498	0.00145	CcSEcCtD
Ticagrelor—Feeling abnormal—Ibandronate—osteoporosis	0.000498	0.00145	CcSEcCtD
Ticagrelor—Skin disorder—Ethinyl Estradiol—osteoporosis	0.000496	0.00145	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Ibandronate—osteoporosis	0.000494	0.00144	CcSEcCtD
Ticagrelor—Back pain—Conjugated Estrogens—osteoporosis	0.000493	0.00144	CcSEcCtD
Ticagrelor—Epistaxis—Estradiol—osteoporosis	0.000493	0.00144	CcSEcCtD
Ticagrelor—Abdominal pain—Alendronate—osteoporosis	0.00049	0.00143	CcSEcCtD
Ticagrelor—Body temperature increased—Alendronate—osteoporosis	0.00049	0.00143	CcSEcCtD
Ticagrelor—Shock—Risedronate—osteoporosis	0.00049	0.00143	CcSEcCtD
Ticagrelor—Nervous system disorder—Risedronate—osteoporosis	0.000488	0.00143	CcSEcCtD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—FGB—osteoporosis	0.000486	0.013	CbGpPWpGaD
Ticagrelor—Angioedema—Zoledronate—osteoporosis	0.000484	0.00141	CcSEcCtD
Ticagrelor—Skin disorder—Risedronate—osteoporosis	0.000483	0.00141	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Calcitriol—osteoporosis	0.000483	0.00141	CcSEcCtD
Ticagrelor—Abdominal pain—Raloxifene—osteoporosis	0.000482	0.00141	CcSEcCtD
Ticagrelor—Body temperature increased—Raloxifene—osteoporosis	0.000482	0.00141	CcSEcCtD
Ticagrelor—Abdominal pain—Ibandronate—osteoporosis	0.000477	0.00139	CcSEcCtD
Ticagrelor—Body temperature increased—Ibandronate—osteoporosis	0.000477	0.00139	CcSEcCtD
Ticagrelor—Confusional state—Pamidronate—osteoporosis	0.000477	0.00139	CcSEcCtD
Ticagrelor—Vertigo—Zoledronate—osteoporosis	0.000476	0.00139	CcSEcCtD
Ticagrelor—Syncope—Zoledronate—osteoporosis	0.000475	0.00139	CcSEcCtD
Ticagrelor—Haemoglobin—Estradiol—osteoporosis	0.000471	0.00138	CcSEcCtD
Ticagrelor—Haemorrhage—Estradiol—osteoporosis	0.000469	0.00137	CcSEcCtD
Ticagrelor—Body temperature increased—Calcitriol—osteoporosis	0.000467	0.00137	CcSEcCtD
Ticagrelor—Abdominal pain—Calcitriol—osteoporosis	0.000467	0.00137	CcSEcCtD
Ticagrelor—P2RY12—Hemostasis—MGLL—osteoporosis	0.000467	0.0125	CbGpPWpGaD
Ticagrelor—Angioedema—Conjugated Estrogens—osteoporosis	0.000466	0.00136	CcSEcCtD
Ticagrelor—Shock—Pamidronate—osteoporosis	0.000465	0.00136	CcSEcCtD
Ticagrelor—Loss of consciousness—Zoledronate—osteoporosis	0.000465	0.00136	CcSEcCtD
Ticagrelor—Hypersensitivity—Estropipate—osteoporosis	0.000464	0.00136	CcSEcCtD
Ticagrelor—Nervous system disorder—Pamidronate—osteoporosis	0.000464	0.00136	CcSEcCtD
Ticagrelor—Urinary tract disorder—Estradiol—osteoporosis	0.000463	0.00135	CcSEcCtD
Ticagrelor—Vomiting—Etidronic acid—osteoporosis	0.000463	0.00135	CcSEcCtD
Ticagrelor—Cough—Zoledronate—osteoporosis	0.000462	0.00135	CcSEcCtD
Ticagrelor—Oedema peripheral—Estradiol—osteoporosis	0.000462	0.00135	CcSEcCtD
Ticagrelor—Connective tissue disorder—Estradiol—osteoporosis	0.000461	0.00135	CcSEcCtD
Ticagrelor—Urethral disorder—Estradiol—osteoporosis	0.000459	0.00134	CcSEcCtD
Ticagrelor—Rash—Etidronic acid—osteoporosis	0.000459	0.00134	CcSEcCtD
Ticagrelor—Dermatitis—Etidronic acid—osteoporosis	0.000459	0.00134	CcSEcCtD
Ticagrelor—Vertigo—Conjugated Estrogens—osteoporosis	0.000458	0.00134	CcSEcCtD
Ticagrelor—Syncope—Conjugated Estrogens—osteoporosis	0.000457	0.00134	CcSEcCtD
Ticagrelor—Hypertension—Zoledronate—osteoporosis	0.000457	0.00134	CcSEcCtD
Ticagrelor—Hypersensitivity—Alendronate—osteoporosis	0.000457	0.00134	CcSEcCtD
Ticagrelor—Headache—Etidronic acid—osteoporosis	0.000456	0.00133	CcSEcCtD
Ticagrelor—Asthenia—Estropipate—osteoporosis	0.000452	0.00132	CcSEcCtD
Ticagrelor—Chest pain—Zoledronate—osteoporosis	0.000451	0.00132	CcSEcCtD
Ticagrelor—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000448	0.00131	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000448	0.00131	CcSEcCtD
Ticagrelor—Paraesthesia—Risedronate—osteoporosis	0.000447	0.00131	CcSEcCtD
Ticagrelor—Pruritus—Estropipate—osteoporosis	0.000446	0.0013	CcSEcCtD
Ticagrelor—Asthenia—Alendronate—osteoporosis	0.000445	0.0013	CcSEcCtD
Ticagrelor—Hypersensitivity—Ibandronate—osteoporosis	0.000445	0.0013	CcSEcCtD
Ticagrelor—Cough—Conjugated Estrogens—osteoporosis	0.000445	0.0013	CcSEcCtD
Ticagrelor—Dyspnoea—Risedronate—osteoporosis	0.000444	0.0013	CcSEcCtD
Ticagrelor—Hypotension—Pamidronate—osteoporosis	0.000442	0.00129	CcSEcCtD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—CNR2—osteoporosis	0.000442	0.0118	CbGpPWpGaD
Ticagrelor—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000441	0.00129	CcSEcCtD
Ticagrelor—Fatigue—Ethinyl Estradiol—osteoporosis	0.00044	0.00129	CcSEcCtD
Ticagrelor—Pruritus—Alendronate—osteoporosis	0.000439	0.00128	CcSEcCtD
Ticagrelor—Dyspepsia—Risedronate—osteoporosis	0.000438	0.00128	CcSEcCtD
Ticagrelor—Eye disorder—Estradiol—osteoporosis	0.000438	0.00128	CcSEcCtD
Ticagrelor—Constipation—Ethinyl Estradiol—osteoporosis	0.000437	0.00128	CcSEcCtD
Ticagrelor—Confusional state—Zoledronate—osteoporosis	0.000436	0.00127	CcSEcCtD
Ticagrelor—Hypersensitivity—Calcitriol—osteoporosis	0.000436	0.00127	CcSEcCtD
Ticagrelor—Cardiac disorder—Estradiol—osteoporosis	0.000435	0.00127	CcSEcCtD
Ticagrelor—Chest pain—Conjugated Estrogens—osteoporosis	0.000434	0.00127	CcSEcCtD
Ticagrelor—Asthenia—Ibandronate—osteoporosis	0.000433	0.00127	CcSEcCtD
Ticagrelor—Nausea—Etidronic acid—osteoporosis	0.000432	0.00126	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000431	0.00126	CcSEcCtD
Ticagrelor—Diarrhoea—Estropipate—osteoporosis	0.000431	0.00126	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Risedronate—osteoporosis	0.00043	0.00126	CcSEcCtD
Ticagrelor—Fatigue—Risedronate—osteoporosis	0.000429	0.00125	CcSEcCtD
Ticagrelor—Pruritus—Ibandronate—osteoporosis	0.000427	0.00125	CcSEcCtD
Ticagrelor—P2RY12—Hemostasis—ANXA2—osteoporosis	0.000427	0.0114	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—PLEK—osteoporosis	0.000427	0.0114	CbGpPWpGaD
Ticagrelor—Constipation—Risedronate—osteoporosis	0.000426	0.00124	CcSEcCtD
Ticagrelor—Angiopathy—Estradiol—osteoporosis	0.000425	0.00124	CcSEcCtD
Ticagrelor—Shock—Zoledronate—osteoporosis	0.000425	0.00124	CcSEcCtD
Ticagrelor—Paraesthesia—Pamidronate—osteoporosis	0.000425	0.00124	CcSEcCtD
Ticagrelor—Diarrhoea—Alendronate—osteoporosis	0.000424	0.00124	CcSEcCtD
Ticagrelor—Asthenia—Calcitriol—osteoporosis	0.000424	0.00124	CcSEcCtD
Ticagrelor—Nervous system disorder—Zoledronate—osteoporosis	0.000424	0.00124	CcSEcCtD
Ticagrelor—Immune system disorder—Estradiol—osteoporosis	0.000423	0.00124	CcSEcCtD
Ticagrelor—Mediastinal disorder—Estradiol—osteoporosis	0.000422	0.00123	CcSEcCtD
Ticagrelor—Dyspnoea—Pamidronate—osteoporosis	0.000422	0.00123	CcSEcCtD
Ticagrelor—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000421	0.00123	CcSEcCtD
Ticagrelor—Skin disorder—Zoledronate—osteoporosis	0.00042	0.00123	CcSEcCtD
Ticagrelor—Pruritus—Calcitriol—osteoporosis	0.000418	0.00122	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000417	0.00122	CcSEcCtD
Ticagrelor—Diarrhoea—Raloxifene—osteoporosis	0.000417	0.00122	CcSEcCtD
Ticagrelor—Dyspepsia—Pamidronate—osteoporosis	0.000416	0.00122	CcSEcCtD
Ticagrelor—Dizziness—Estropipate—osteoporosis	0.000416	0.00122	CcSEcCtD
Ticagrelor—Diarrhoea—Ibandronate—osteoporosis	0.000413	0.00121	CcSEcCtD
Ticagrelor—Mental disorder—Estradiol—osteoporosis	0.000411	0.0012	CcSEcCtD
Ticagrelor—Dizziness—Alendronate—osteoporosis	0.00041	0.0012	CcSEcCtD
Ticagrelor—Shock—Conjugated Estrogens—osteoporosis	0.000409	0.0012	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000408	0.00119	CcSEcCtD
Ticagrelor—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000408	0.00119	CcSEcCtD
Ticagrelor—Malnutrition—Estradiol—osteoporosis	0.000408	0.00119	CcSEcCtD
Ticagrelor—Fatigue—Pamidronate—osteoporosis	0.000408	0.00119	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Risedronate—osteoporosis	0.000407	0.00119	CcSEcCtD
Ticagrelor—Constipation—Pamidronate—osteoporosis	0.000405	0.00118	CcSEcCtD
Ticagrelor—Diarrhoea—Calcitriol—osteoporosis	0.000404	0.00118	CcSEcCtD
Ticagrelor—Skin disorder—Conjugated Estrogens—osteoporosis	0.000404	0.00118	CcSEcCtD
Ticagrelor—Hypotension—Zoledronate—osteoporosis	0.000404	0.00118	CcSEcCtD
Ticagrelor—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000404	0.00118	CcSEcCtD
Ticagrelor—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000404	0.00118	CcSEcCtD
Ticagrelor—Dizziness—Raloxifene—osteoporosis	0.000403	0.00118	CcSEcCtD
Ticagrelor—Vomiting—Estropipate—osteoporosis	0.0004	0.00117	CcSEcCtD
Ticagrelor—Dizziness—Ibandronate—osteoporosis	0.000399	0.00117	CcSEcCtD
Ticagrelor—Rash—Estropipate—osteoporosis	0.000397	0.00116	CcSEcCtD
Ticagrelor—Dermatitis—Estropipate—osteoporosis	0.000397	0.00116	CcSEcCtD
Ticagrelor—Back pain—Estradiol—osteoporosis	0.000395	0.00115	CcSEcCtD
Ticagrelor—Headache—Estropipate—osteoporosis	0.000395	0.00115	CcSEcCtD
Ticagrelor—Vomiting—Alendronate—osteoporosis	0.000394	0.00115	CcSEcCtD
Ticagrelor—Abdominal pain—Risedronate—osteoporosis	0.000393	0.00115	CcSEcCtD
Ticagrelor—Body temperature increased—Risedronate—osteoporosis	0.000393	0.00115	CcSEcCtD
Ticagrelor—Rash—Alendronate—osteoporosis	0.000391	0.00114	CcSEcCtD
Ticagrelor—Dermatitis—Alendronate—osteoporosis	0.000391	0.00114	CcSEcCtD
Ticagrelor—Feeling abnormal—Pamidronate—osteoporosis	0.00039	0.00114	CcSEcCtD
Ticagrelor—Hypotension—Conjugated Estrogens—osteoporosis	0.000389	0.00114	CcSEcCtD
Ticagrelor—Headache—Alendronate—osteoporosis	0.000389	0.00114	CcSEcCtD
Ticagrelor—Paraesthesia—Zoledronate—osteoporosis	0.000388	0.00113	CcSEcCtD
Ticagrelor—Vomiting—Raloxifene—osteoporosis	0.000388	0.00113	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Pamidronate—osteoporosis	0.000387	0.00113	CcSEcCtD
Ticagrelor—Dyspnoea—Zoledronate—osteoporosis	0.000385	0.00113	CcSEcCtD
Ticagrelor—Rash—Raloxifene—osteoporosis	0.000385	0.00112	CcSEcCtD
Ticagrelor—Dermatitis—Raloxifene—osteoporosis	0.000384	0.00112	CcSEcCtD
Ticagrelor—Vomiting—Ibandronate—osteoporosis	0.000384	0.00112	CcSEcCtD
Ticagrelor—Headache—Raloxifene—osteoporosis	0.000382	0.00112	CcSEcCtD
Ticagrelor—Rash—Ibandronate—osteoporosis	0.000381	0.00111	CcSEcCtD
Ticagrelor—Dermatitis—Ibandronate—osteoporosis	0.00038	0.00111	CcSEcCtD
Ticagrelor—Dyspepsia—Zoledronate—osteoporosis	0.00038	0.00111	CcSEcCtD
Ticagrelor—Headache—Ibandronate—osteoporosis	0.000378	0.00111	CcSEcCtD
Ticagrelor—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000376	0.0011	CcSEcCtD
Ticagrelor—Vomiting—Calcitriol—osteoporosis	0.000376	0.0011	CcSEcCtD
Ticagrelor—Nausea—Estropipate—osteoporosis	0.000374	0.00109	CcSEcCtD
Ticagrelor—Abdominal pain—Pamidronate—osteoporosis	0.000374	0.00109	CcSEcCtD
Ticagrelor—Body temperature increased—Pamidronate—osteoporosis	0.000374	0.00109	CcSEcCtD
Ticagrelor—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000374	0.00109	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000373	0.00109	CcSEcCtD
Ticagrelor—Angioedema—Estradiol—osteoporosis	0.000373	0.00109	CcSEcCtD
Ticagrelor—Rash—Calcitriol—osteoporosis	0.000373	0.00109	CcSEcCtD
Ticagrelor—Fatigue—Zoledronate—osteoporosis	0.000373	0.00109	CcSEcCtD
Ticagrelor—Dermatitis—Calcitriol—osteoporosis	0.000372	0.00109	CcSEcCtD
Ticagrelor—P2RY12—GPCR downstream signaling—CALCR—osteoporosis	0.000371	0.00996	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—PTH1R—osteoporosis	0.000371	0.00996	CbGpPWpGaD
Ticagrelor—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000371	0.00108	CcSEcCtD
Ticagrelor—Headache—Calcitriol—osteoporosis	0.00037	0.00108	CcSEcCtD
Ticagrelor—Constipation—Zoledronate—osteoporosis	0.00037	0.00108	CcSEcCtD
Ticagrelor—Nausea—Alendronate—osteoporosis	0.000368	0.00108	CcSEcCtD
Ticagrelor—P2RY12—Hemostasis—TLN1—osteoporosis	0.000368	0.00987	CbGpPWpGaD
Ticagrelor—Hypersensitivity—Risedronate—osteoporosis	0.000367	0.00107	CcSEcCtD
Ticagrelor—Vertigo—Estradiol—osteoporosis	0.000367	0.00107	CcSEcCtD
Ticagrelor—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000366	0.00107	CcSEcCtD
Ticagrelor—Asthenia—Ethinyl Estradiol—osteoporosis	0.000366	0.00107	CcSEcCtD
Ticagrelor—Syncope—Estradiol—osteoporosis	0.000366	0.00107	CcSEcCtD
Ticagrelor—P2RY12—Hemostasis—VCL—osteoporosis	0.000363	0.00973	CbGpPWpGaD
Ticagrelor—Nausea—Raloxifene—osteoporosis	0.000362	0.00106	CcSEcCtD
Ticagrelor—Pruritus—Ethinyl Estradiol—osteoporosis	0.000361	0.00106	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000359	0.00105	CcSEcCtD
Ticagrelor—Fatigue—Conjugated Estrogens—osteoporosis	0.000359	0.00105	CcSEcCtD
Ticagrelor—Nausea—Ibandronate—osteoporosis	0.000359	0.00105	CcSEcCtD
Ticagrelor—Loss of consciousness—Estradiol—osteoporosis	0.000359	0.00105	CcSEcCtD
Ticagrelor—Asthenia—Risedronate—osteoporosis	0.000357	0.00104	CcSEcCtD
Ticagrelor—Feeling abnormal—Zoledronate—osteoporosis	0.000356	0.00104	CcSEcCtD
Ticagrelor—Cough—Estradiol—osteoporosis	0.000356	0.00104	CcSEcCtD
Ticagrelor—Constipation—Conjugated Estrogens—osteoporosis	0.000356	0.00104	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Zoledronate—osteoporosis	0.000353	0.00103	CcSEcCtD
Ticagrelor—Hypertension—Estradiol—osteoporosis	0.000352	0.00103	CcSEcCtD
Ticagrelor—Pruritus—Risedronate—osteoporosis	0.000352	0.00103	CcSEcCtD
Ticagrelor—Nausea—Calcitriol—osteoporosis	0.000351	0.00103	CcSEcCtD
Ticagrelor—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000349	0.00102	CcSEcCtD
Ticagrelor—Hypersensitivity—Pamidronate—osteoporosis	0.000349	0.00102	CcSEcCtD
Ticagrelor—Chest pain—Estradiol—osteoporosis	0.000347	0.00102	CcSEcCtD
Ticagrelor—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	0.000347	0.0093	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—PTH—osteoporosis	0.000345	0.00926	CbGpPWpGaD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000345	0.00101	CcSEcCtD
Ticagrelor—Body temperature increased—Zoledronate—osteoporosis	0.000342	0.000998	CcSEcCtD
Ticagrelor—Abdominal pain—Zoledronate—osteoporosis	0.000342	0.000998	CcSEcCtD
Ticagrelor—Diarrhoea—Risedronate—osteoporosis	0.000341	0.000995	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.00034	0.000994	CcSEcCtD
Ticagrelor—Asthenia—Pamidronate—osteoporosis	0.000339	0.000992	CcSEcCtD
Ticagrelor—Dizziness—Ethinyl Estradiol—osteoporosis	0.000338	0.000986	CcSEcCtD
Ticagrelor—P2RY12—Signaling by GPCR—PTH1R—osteoporosis	0.000337	0.00904	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—CALCR—osteoporosis	0.000337	0.00904	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—CNR2—osteoporosis	0.000337	0.00902	CbGpPWpGaD
Ticagrelor—Confusional state—Estradiol—osteoporosis	0.000336	0.000981	CcSEcCtD
Ticagrelor—Pruritus—Pamidronate—osteoporosis	0.000335	0.000978	CcSEcCtD
Ticagrelor—Dizziness—Risedronate—osteoporosis	0.000329	0.000962	CcSEcCtD
Ticagrelor—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000329	0.000961	CcSEcCtD
Ticagrelor—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000329	0.000961	CcSEcCtD
Ticagrelor—Shock—Estradiol—osteoporosis	0.000328	0.000957	CcSEcCtD
Ticagrelor—Nervous system disorder—Estradiol—osteoporosis	0.000327	0.000954	CcSEcCtD
Ticagrelor—Vomiting—Ethinyl Estradiol—osteoporosis	0.000325	0.000948	CcSEcCtD
Ticagrelor—Diarrhoea—Pamidronate—osteoporosis	0.000324	0.000946	CcSEcCtD
Ticagrelor—Skin disorder—Estradiol—osteoporosis	0.000323	0.000945	CcSEcCtD
Ticagrelor—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000323	0.00867	CbGpPWpGaD
Ticagrelor—Rash—Ethinyl Estradiol—osteoporosis	0.000322	0.00094	CcSEcCtD
Ticagrelor—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000322	0.00094	CcSEcCtD
Ticagrelor—Headache—Ethinyl Estradiol—osteoporosis	0.00032	0.000934	CcSEcCtD
Ticagrelor—Hypersensitivity—Zoledronate—osteoporosis	0.000318	0.00093	CcSEcCtD
Ticagrelor—Vomiting—Risedronate—osteoporosis	0.000316	0.000925	CcSEcCtD
Ticagrelor—P2RY12—GPCR ligand binding—WNT1—osteoporosis	0.000316	0.00848	CbGpPWpGaD
Ticagrelor—Rash—Risedronate—osteoporosis	0.000314	0.000917	CcSEcCtD
Ticagrelor—Dermatitis—Risedronate—osteoporosis	0.000314	0.000916	CcSEcCtD
Ticagrelor—Dizziness—Pamidronate—osteoporosis	0.000313	0.000914	CcSEcCtD
Ticagrelor—Headache—Risedronate—osteoporosis	0.000312	0.000911	CcSEcCtD
Ticagrelor—Asthenia—Zoledronate—osteoporosis	0.00031	0.000906	CcSEcCtD
Ticagrelor—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000307	0.000896	CcSEcCtD
Ticagrelor—Pruritus—Zoledronate—osteoporosis	0.000306	0.000893	CcSEcCtD
Ticagrelor—P2RY12—Hemostasis—RAP1A—osteoporosis	0.000303	0.00813	CbGpPWpGaD
Ticagrelor—Nausea—Ethinyl Estradiol—osteoporosis	0.000303	0.000886	CcSEcCtD
Ticagrelor—Vomiting—Pamidronate—osteoporosis	0.000301	0.000879	CcSEcCtD
Ticagrelor—Paraesthesia—Estradiol—osteoporosis	0.000299	0.000874	CcSEcCtD
Ticagrelor—Asthenia—Conjugated Estrogens—osteoporosis	0.000299	0.000872	CcSEcCtD
Ticagrelor—Rash—Pamidronate—osteoporosis	0.000298	0.000872	CcSEcCtD
Ticagrelor—Dermatitis—Pamidronate—osteoporosis	0.000298	0.000871	CcSEcCtD
Ticagrelor—Dyspnoea—Estradiol—osteoporosis	0.000297	0.000868	CcSEcCtD
Ticagrelor—Headache—Pamidronate—osteoporosis	0.000296	0.000866	CcSEcCtD
Ticagrelor—P2RY12—G alpha (i) signalling events—ADCY5—osteoporosis	0.000296	0.00793	CbGpPWpGaD
Ticagrelor—Diarrhoea—Zoledronate—osteoporosis	0.000296	0.000864	CcSEcCtD
Ticagrelor—Nausea—Risedronate—osteoporosis	0.000296	0.000864	CcSEcCtD
Ticagrelor—P2RY12—GPCR downstream signaling—MGLL—osteoporosis	0.000295	0.00791	CbGpPWpGaD
Ticagrelor—Pruritus—Conjugated Estrogens—osteoporosis	0.000294	0.00086	CcSEcCtD
Ticagrelor—Dyspepsia—Estradiol—osteoporosis	0.000293	0.000857	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Estradiol—osteoporosis	0.000288	0.00084	CcSEcCtD
Ticagrelor—Fatigue—Estradiol—osteoporosis	0.000287	0.000839	CcSEcCtD
Ticagrelor—P2RY12—GPCR ligand binding—PTHLH—osteoporosis	0.000286	0.00767	CbGpPWpGaD
Ticagrelor—Dizziness—Zoledronate—osteoporosis	0.000286	0.000835	CcSEcCtD
Ticagrelor—Constipation—Estradiol—osteoporosis	0.000285	0.000832	CcSEcCtD
Ticagrelor—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000285	0.000832	CcSEcCtD
Ticagrelor—Nausea—Pamidronate—osteoporosis	0.000281	0.000821	CcSEcCtD
Ticagrelor—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000275	0.00738	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—FGA—osteoporosis	0.000275	0.00738	CbGpPWpGaD
Ticagrelor—Dizziness—Conjugated Estrogens—osteoporosis	0.000275	0.000804	CcSEcCtD
Ticagrelor—Vomiting—Zoledronate—osteoporosis	0.000275	0.000803	CcSEcCtD
Ticagrelor—Feeling abnormal—Estradiol—osteoporosis	0.000274	0.000802	CcSEcCtD
Ticagrelor—Rash—Zoledronate—osteoporosis	0.000272	0.000796	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Estradiol—osteoporosis	0.000272	0.000796	CcSEcCtD
Ticagrelor—Dermatitis—Zoledronate—osteoporosis	0.000272	0.000795	CcSEcCtD
Ticagrelor—ABCB1—HIF-1-alpha transcription factor network—ENO1—osteoporosis	0.000272	0.0073	CbGpPWpGaD
Ticagrelor—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000272	0.00729	CbGpPWpGaD
Ticagrelor—Headache—Zoledronate—osteoporosis	0.000271	0.000791	CcSEcCtD
Ticagrelor—P2RY12—Signaling by GPCR—MGLL—osteoporosis	0.000268	0.00718	CbGpPWpGaD
Ticagrelor—Vomiting—Conjugated Estrogens—osteoporosis	0.000265	0.000773	CcSEcCtD
Ticagrelor—Body temperature increased—Estradiol—osteoporosis	0.000263	0.000769	CcSEcCtD
Ticagrelor—Abdominal pain—Estradiol—osteoporosis	0.000263	0.000769	CcSEcCtD
Ticagrelor—Rash—Conjugated Estrogens—osteoporosis	0.000262	0.000767	CcSEcCtD
Ticagrelor—Dermatitis—Conjugated Estrogens—osteoporosis	0.000262	0.000766	CcSEcCtD
Ticagrelor—Headache—Conjugated Estrogens—osteoporosis	0.000261	0.000762	CcSEcCtD
Ticagrelor—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—osteoporosis	0.000259	0.00696	CbGpPWpGaD
Ticagrelor—Nausea—Zoledronate—osteoporosis	0.000257	0.00075	CcSEcCtD
Ticagrelor—P2RY12—GPCR ligand binding—CALCA—osteoporosis	0.000252	0.00675	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—FGB—osteoporosis	0.00025	0.00671	CbGpPWpGaD
Ticagrelor—Nausea—Conjugated Estrogens—osteoporosis	0.000247	0.000722	CcSEcCtD
Ticagrelor—Hypersensitivity—Estradiol—osteoporosis	0.000245	0.000717	CcSEcCtD
Ticagrelor—Asthenia—Estradiol—osteoporosis	0.000239	0.000698	CcSEcCtD
Ticagrelor—Pruritus—Estradiol—osteoporosis	0.000236	0.000688	CcSEcCtD
Ticagrelor—Diarrhoea—Estradiol—osteoporosis	0.000228	0.000666	CcSEcCtD
Ticagrelor—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000223	0.00598	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—SOST—osteoporosis	0.00022	0.00591	CbGpPWpGaD
Ticagrelor—Dizziness—Estradiol—osteoporosis	0.00022	0.000643	CcSEcCtD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—IGF1—osteoporosis	0.00022	0.0059	CbGpPWpGaD
Ticagrelor—P2RY12—G alpha (i) signalling events—POMC—osteoporosis	0.000218	0.00583	CbGpPWpGaD
Ticagrelor—Vomiting—Estradiol—osteoporosis	0.000212	0.000619	CcSEcCtD
Ticagrelor—Rash—Estradiol—osteoporosis	0.00021	0.000614	CcSEcCtD
Ticagrelor—Dermatitis—Estradiol—osteoporosis	0.00021	0.000613	CcSEcCtD
Ticagrelor—Headache—Estradiol—osteoporosis	0.000209	0.00061	CcSEcCtD
Ticagrelor—P2RY12—Signaling Pathways—PTH1R—osteoporosis	0.000199	0.00534	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CALCR—osteoporosis	0.000199	0.00534	CbGpPWpGaD
Ticagrelor—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000199	0.00534	CbGpPWpGaD
Ticagrelor—Nausea—Estradiol—osteoporosis	0.000198	0.000578	CcSEcCtD
Ticagrelor—P2RY12—GPCR downstream signaling—PTH—osteoporosis	0.000195	0.00523	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—CNR2—osteoporosis	0.00019	0.0051	CbGpPWpGaD
Ticagrelor—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	0.000179	0.0048	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—PTH—osteoporosis	0.000177	0.00475	CbGpPWpGaD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.000173	0.00464	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—CNR2—osteoporosis	0.000173	0.00463	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—WNT1—osteoporosis	0.000162	0.00435	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—PTHLH—osteoporosis	0.000162	0.00433	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—MGLL—osteoporosis	0.000158	0.00424	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—LRP5—osteoporosis	0.000155	0.00414	CbGpPWpGaD
Ticagrelor—ABCB1—HIF-1-alpha transcription factor network—LEP—osteoporosis	0.000152	0.00408	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—LRP6—osteoporosis	0.000148	0.00396	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—PTHLH—osteoporosis	0.000147	0.00394	CbGpPWpGaD
Ticagrelor—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000145	0.00388	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	0.000144	0.00386	CbGpPWpGaD
Ticagrelor—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000143	0.00383	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—CALCA—osteoporosis	0.000142	0.00382	CbGpPWpGaD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	0.000132	0.00353	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—POMC—osteoporosis	0.000132	0.00353	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—CALCA—osteoporosis	0.000129	0.00347	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—TLN1—osteoporosis	0.000125	0.00335	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	0.000119	0.00318	CbGpPWpGaD
Ticagrelor—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000117	0.00314	CbGpPWpGaD
Ticagrelor—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	0.000117	0.00314	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—IGF1—osteoporosis	0.000113	0.00304	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—P4HB—osteoporosis	0.000108	0.00288	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PTH—osteoporosis	0.000105	0.00281	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—RAP1A—osteoporosis	0.000103	0.00276	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	0.000102	0.00274	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CNR2—osteoporosis	0.000102	0.00273	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—ADCY5—osteoporosis	0.000101	0.00271	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—NFATC1—osteoporosis	0.0001	0.00269	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—DKK1—osteoporosis	9.96e-05	0.00267	CbGpPWpGaD
Ticagrelor—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—osteoporosis	9.59e-05	0.00257	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—WNT1—osteoporosis	9.59e-05	0.00257	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—FGA—osteoporosis	9.33e-05	0.0025	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—ADCY5—osteoporosis	9.2e-05	0.00246	CbGpPWpGaD
Ticagrelor—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	8.69e-05	0.00233	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PTHLH—osteoporosis	8.67e-05	0.00233	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—BMP2—osteoporosis	8.67e-05	0.00233	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—FGB—osteoporosis	8.49e-05	0.00228	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—IL1B—osteoporosis	8.4e-05	0.00225	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PSMA2—osteoporosis	8.19e-05	0.0022	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PSMA5—osteoporosis	8.19e-05	0.0022	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—ANXA2—osteoporosis	8.04e-05	0.00216	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CALCA—osteoporosis	7.64e-05	0.00205	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—POMC—osteoporosis	7.45e-05	0.002	CbGpPWpGaD
Ticagrelor—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	7.05e-05	0.00189	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—KL—osteoporosis	6.93e-05	0.00186	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—TGFB1—osteoporosis	6.8e-05	0.00182	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—POMC—osteoporosis	6.76e-05	0.00181	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—IL6R—osteoporosis	6.6e-05	0.00177	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—TGFB1—osteoporosis	6.53e-05	0.00175	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	6.23e-05	0.00167	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	6.21e-05	0.00166	CbGpPWpGaD
Ticagrelor—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	6.14e-05	0.00165	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—TNF—osteoporosis	6.1e-05	0.00163	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—FDPS—osteoporosis	5.73e-05	0.00154	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PKM—osteoporosis	5.73e-05	0.00154	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GPD2—osteoporosis	5.43e-05	0.00146	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PGLS—osteoporosis	5.43e-05	0.00146	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—ADCY5—osteoporosis	5.43e-05	0.00146	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	5.38e-05	0.00144	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—SPP1—osteoporosis	5.26e-05	0.00141	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PNP—osteoporosis	4.97e-05	0.00133	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ATIC—osteoporosis	4.97e-05	0.00133	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—IRS2—osteoporosis	4.75e-05	0.00127	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—LEP—osteoporosis	4.65e-05	0.00125	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—ESR1—osteoporosis	4.44e-05	0.00119	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CA2—osteoporosis	4.23e-05	0.00113	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—OXCT1—osteoporosis	4.23e-05	0.00113	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—IRS1—osteoporosis	4.15e-05	0.00111	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—MGLL—osteoporosis	4.12e-05	0.0011	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—POMC—osteoporosis	4e-05	0.00107	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—IL6R—osteoporosis	3.9e-05	0.00104	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—IGF1—osteoporosis	3.84e-05	0.00103	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—POMC—osteoporosis	3.74e-05	0.001	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PKM—osteoporosis	3.53e-05	0.000947	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—FDPS—osteoporosis	3.53e-05	0.000947	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—IDH2—osteoporosis	3.5e-05	0.000938	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GPD2—osteoporosis	3.35e-05	0.000897	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PGLS—osteoporosis	3.35e-05	0.000897	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CYP27A1—osteoporosis	3.29e-05	0.000882	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	3.23e-05	0.000866	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	3.22e-05	0.000864	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ACP5—osteoporosis	3.2e-05	0.000858	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PNP—osteoporosis	3.06e-05	0.000821	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ATIC—osteoporosis	3.06e-05	0.000821	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	3.02e-05	0.000809	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	3.01e-05	0.000807	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—TPI1—osteoporosis	2.98e-05	0.000798	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—IL6—osteoporosis	2.94e-05	0.000788	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—P4HB—osteoporosis	2.8e-05	0.00075	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GAPDH—osteoporosis	2.75e-05	0.000736	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—RAP1A—osteoporosis	2.68e-05	0.000717	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CA2—osteoporosis	2.6e-05	0.000698	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—OXCT1—osteoporosis	2.6e-05	0.000698	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—MGLL—osteoporosis	2.54e-05	0.00068	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—MYC—osteoporosis	2.31e-05	0.000619	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—TGFB1—osteoporosis	2.3e-05	0.000618	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ENO1—osteoporosis	2.16e-05	0.00058	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—IDH2—osteoporosis	2.16e-05	0.000578	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PSMA2—osteoporosis	2.13e-05	0.000571	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PSMA5—osteoporosis	2.13e-05	0.000571	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CYP27A1—osteoporosis	2.03e-05	0.000544	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ACP5—osteoporosis	1.97e-05	0.000529	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—TPI1—osteoporosis	1.83e-05	0.000492	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—IL6—osteoporosis	1.74e-05	0.000465	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CYP19A1—osteoporosis	1.73e-05	0.000464	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—P4HB—osteoporosis	1.72e-05	0.000462	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GAPDH—osteoporosis	1.69e-05	0.000454	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—RAP1A—osteoporosis	1.65e-05	0.000442	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ADCY5—osteoporosis	1.41e-05	0.000379	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GPX1—osteoporosis	1.41e-05	0.000377	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ENO1—osteoporosis	1.33e-05	0.000357	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PSMA2—osteoporosis	1.31e-05	0.000352	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PSMA5—osteoporosis	1.31e-05	0.000352	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—MTHFR—osteoporosis	1.3e-05	0.000348	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CYP19A1—osteoporosis	1.07e-05	0.000286	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—POMC—osteoporosis	1.04e-05	0.000279	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ADCY5—osteoporosis	8.7e-06	0.000233	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GPX1—osteoporosis	8.67e-06	0.000233	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—MTHFR—osteoporosis	8.01e-06	0.000215	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—POMC—osteoporosis	6.4e-06	0.000172	CbGpPWpGaD
